CAS: 1007106-86-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Fezakinumab REF: TM-T76775CAS: 1007106-86-6 | SDS-PAGE:95% SEC-HPLC:95% | 213.00 €~2,209.00 € | Tue 29 Oct 24 |
 | Fezakinumab REF: 3D-CLA1242CAS: 1007106-86-6 | - - - | To inquire | Wed 06 Nov 24 |
Fezakinumab
CAS:1007106-86-6
Fezakinumab: a monoclonal antibody targeting IL-22; used in researching psoriasis, arthritis, dermatitis.
Purity:
SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Ref: TM-T76775
| 1mg | 213.00 € | ||
| 5mg | 523.00 € | ||
| 10mg | 813.00 € | ||
| 25mg | 1,226.00 € | ||
| 50mg | 1,652.00 € | ||
| 100mg | 2,209.00 € |
Estimated delivery in United States, on Tuesday 29 Oct 2024
Ref: 3D-CLA1242
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
